AURKA and gastric cancer: A small selective inhibitor of AURKA MLN8237 (Alisertib) suppressed NF-κB activity in human gastric cancer samples and mouse epithelial cells, and reduced expression of NF-κB target genes that regulate inflammation and cell survival.